Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q63977999 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000213.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q63977999 | ||
| 024 | ‡a 0000-0001-7147-4594 ‡2 orcid | ||
| 024 | ‡a 57201491381 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q63977999 | ||
| 100 | 0 | ‡a Jan-Michael Werner ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Jan-Michael Werner ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients | ||
| 670 | ‡a Author's Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors | ||
| 670 | ‡a Author's Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation. | ||
| 670 | ‡a Author's Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas | ||
| 670 | ‡a Author's Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI | ||
| 670 | ‡a Author's Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy | ||
| 670 | ‡a Author's Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas | ||
| 670 | ‡a Author's Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival | ||
| 670 | ‡a Author's FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation | ||
| 670 | ‡a Author's FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma | ||
| 670 | ‡a Author's Flare phenomenon in O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas | ||
| 670 | ‡a Author's Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression | ||
| 670 | ‡a Author's Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI | ||
| 670 | ‡a Author's Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a Isocitrate Dehydrogenase- and B-Raf Proto-Oncogene-Wildtype Epithelioid Glioblastoma | ||
| 670 | ‡a Author's Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors | ||
| 670 | ‡a Author's Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET | ||
| 670 | ‡a Author's Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma | ||
| 909 | ‡a (orcid) 0000000171474594 ‡9 1 | ||
| 909 | ‡a (scopus) 57201491381 ‡9 1 | ||
| 919 | ‡a combinedaminoacidpositronemissiontomographyandadvancedmagneticresonanceimagingingliomapatients ‡A Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients ‡9 1 | ||
| 919 | ‡a currentlandscapeandemergingfieldsofpetimaginginpatientswithbraintumors ‡A Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors ‡9 1 | ||
| 919 | ‡a dabrafenibtreatmentinapatientwithanepithelioidglioblastomaandbrafv600emutation ‡A Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation. ‡9 1 | ||
| 919 | ‡a deathreceptor6dr6isoverexpressedinastrocytomas ‡A Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas ‡9 1 | ||
| 919 | ‡a differentiationoftreatmentrelatedchangesfromtumourprogressionadirectcomparisonbetweendynamicfetpetandadcvaluesobtainedfromdwimri ‡A Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI ‡9 1 | ||
| 919 | ‡a discordanceandconversionratesofprogesteroneestrogenandher2neureceptorstatusinprimarybreastcancerandbrainmetastasismainlytriggeredbyhormonetherapy ‡A Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy ‡9 1 | ||
| 919 | ‡a expressionofcd40correlatesnegativelywithoverallandprogressionfreesurvivaloflowandhighgradegliomas ‡A Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas ‡9 1 | ||
| 919 | ‡a expressionoffas50differsfromprimarytorelapsedlowgradegliomasandpredictsprogressionfreesurvival ‡A Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival ‡9 1 | ||
| 919 | ‡a fetpetradiomicsfordifferentiatingpseudoprogressionfromearlytumorprogressioningliomapatientspostchemoradiation ‡A FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation ‡9 1 | ||
| 919 | ‡a fetpetrevealsconsiderablespatialdifferencesintumourburdencomparedtoconventionalmriinnewlydiagnosedglioblastoma ‡A FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma ‡9 1 | ||
| 919 | ‡a flarephenomenonino2fluoroethyl50tyrosinepetafterresectionofgliomas ‡A Flare phenomenon in O-(2-[18F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas ‡9 1 | ||
| 919 | ‡a imagingchallengesofimmunotherapyandtargetedtherapyinpatientswithbrainmetastasesresponseprogressionandpseudoprogression ‡A Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression ‡9 1 | ||
| 919 | ‡a imagingfindingsfollowingregorafenibinmalignantgliomasfetpetaddsvaluableinformationtoanatomicalmri ‡A Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI ‡9 1 | ||
| 919 | ‡a magneticresonanceimagingrevealsapronouncedtreatmentresponseofaisocitratedehydrogenaseandbrafprotooncogenewildtypeepithelioidglioblastoma ‡A Magnetic Resonance Imaging Reveals a Pronounced Treatment Response of a Isocitrate Dehydrogenase- and B-Raf Proto-Oncogene-Wildtype Epithelioid Glioblastoma ‡9 1 | ||
| 919 | ‡a molecularimagingandadvancedmrifindingsfollowingimmunotherapyinpatientswithbraintumors ‡A Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors ‡9 1 | ||
| 919 | ‡a predictionofsurvivalinpatientswithidhwildtypeastrocyticgliomasusingdynamico2fluoroethyl50tyrosinepet ‡A Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET ‡9 1 | ||
| 919 | ‡a successfultreatmentofmyastheniagravisfollowingpd1ctla4combinationcheckpointblockadeinapatientwithmetastaticmelanoma ‡A Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma ‡9 1 | ||
| 996 | ‡2 NKC|utb2015875286 | ||
| 996 | ‡2 PLWABN|9810640283005606 | ||
| 996 | ‡2 ISNI|0000000009423916 | ||
| 996 | ‡2 ISNI|000000037314987X | ||
| 996 | ‡2 ISNI|0000000016188125 | ||
| 996 | ‡2 J9U|987007400035405171 | ||
| 996 | ‡2 RERO|A017031096 | ||
| 996 | ‡2 SUDOC|108390322 | ||
| 996 | ‡2 BIBSYS|12074269 | ||
| 996 | ‡2 DNB|1146708211 | ||
| 996 | ‡2 BIBSYS|6049030 | ||
| 996 | ‡2 NUKAT|n 2006034556 | ||
| 996 | ‡2 W2Z|1560455411072 | ||
| 996 | ‡2 ISNI|0000000363137277 | ||
| 996 | ‡2 SUDOC|237418541 | ||
| 996 | ‡2 NTA|108883906 | ||
| 996 | ‡2 BIBSYS|10038872 | ||
| 996 | ‡2 ISNI|0000000013204011 | ||
| 996 | ‡2 ISNI|0000000396810149 | ||
| 996 | ‡2 NTA|324983344 | ||
| 996 | ‡2 LC|n 79088824 | ||
| 996 | ‡2 DNB|1089976283 | ||
| 996 | ‡2 DNB|100702635 | ||
| 996 | ‡2 SUDOC|177152486 | ||
| 996 | ‡2 J9U|987007398753205171 | ||
| 996 | ‡2 DNB|1174820276 | ||
| 996 | ‡2 LC|no2007023054 | ||
| 996 | ‡2 BNF|14467499 | ||
| 996 | ‡2 SZ|117304050 | ||
| 996 | ‡2 NKC|xx0272918 | ||
| 996 | ‡2 NII|DA1140123X | ||
| 996 | ‡2 ISNI|0000000066894263 | ||
| 996 | ‡2 SUDOC|177507098 | ||
| 996 | ‡2 DNB|119868008 | ||
| 996 | ‡2 J9U|987007422220005171 | ||
| 996 | ‡2 SUDOC|240092422 | ||
| 996 | ‡2 LC|n 80155189 | ||
| 996 | ‡2 RERO|A022760302 | ||
| 996 | ‡2 BNF|12378015 | ||
| 996 | ‡2 NSK|000066160 | ||
| 996 | ‡2 ISNI|0000000030685996 | ||
| 996 | ‡2 BIBSYS|2137132 | ||
| 996 | ‡2 RERO|A016635304 | ||
| 996 | ‡2 BIBSYS|1581514959281 | ||
| 996 | ‡2 BNF|12273782 | ||
| 996 | ‡2 NII|DA14478219 | ||
| 996 | ‡2 SUDOC|156618753 | ||
| 996 | ‡2 DNB|1147387958 | ||
| 996 | ‡2 DE633|pe30112993 | ||
| 996 | ‡2 LC|no2015007529 | ||
| 996 | ‡2 DNB|1052640362 | ||
| 996 | ‡2 NUKAT|n 02031804 | ||
| 996 | ‡2 PTBNP|1646292 | ||
| 996 | ‡2 ISNI|0000000019538282 | ||
| 996 | ‡2 DNB|1201207819 | ||
| 996 | ‡2 BIBSYS|4012153 | ||
| 996 | ‡2 NUKAT|n 2021081538 | ||
| 996 | ‡2 BIBSYS|90830236 | ||
| 996 | ‡2 ISNI|0000000430927878 | ||
| 996 | ‡2 NKC|jo2017951732 | ||
| 996 | ‡2 SUDOC|28061666X | ||
| 996 | ‡2 DNB|1051407559 | ||
| 996 | ‡2 ISNI|0000000111451171 | ||
| 996 | ‡2 DNB|134793625 | ||
| 996 | ‡2 NTA|260377449 | ||
| 996 | ‡2 DNB|1159512825 | ||
| 996 | ‡2 PLWABN|9810535266105606 | ||
| 996 | ‡2 NUKAT|n 97062678 | ||
| 996 | ‡2 NTA|252296982 | ||
| 996 | ‡2 DNB|1285638018 | ||
| 996 | ‡2 B2Q|0001241984 | ||
| 996 | ‡2 DNB|106314311X | ||
| 996 | ‡2 W2Z|1581514959281 | ||
| 996 | ‡2 PLWABN|9810609244505606 | ||
| 996 | ‡2 DNB|1225485398 | ||
| 996 | ‡2 BNF|14516992 | ||
| 996 | ‡2 BIBSYS|90370835 | ||
| 996 | ‡2 ISNI|0000000089271042 | ||
| 996 | ‡2 PLWABN|9810552425905606 | ||
| 996 | ‡2 SUDOC|084692618 | ||
| 996 | ‡2 DNB|1160254753 | ||
| 996 | ‡2 DNB|1071216015 | ||
| 996 | ‡2 DE633|pe30041928 | ||
| 996 | ‡2 DNB|170175316 | ||
| 996 | ‡2 NUKAT|n 2019009595 | ||
| 996 | ‡2 PLWABN|9812644666205606 | ||
| 996 | ‡2 DNB|130612537 | ||
| 996 | ‡2 ISNI|0000000060204321 | ||
| 996 | ‡2 DNB|121541851 | ||
| 996 | ‡2 PLWABN|9810594452905606 | ||
| 996 | ‡2 NTA|098381113 | ||
| 996 | ‡2 DNB|1272553787 | ||
| 996 | ‡2 RERO|A003968586 | ||
| 996 | ‡2 NKC|mzk20231195849 | ||
| 996 | ‡2 BNF|12384707 | ||
| 996 | ‡2 NUKAT|n 2015066235 | ||
| 996 | ‡2 BLBNB|001509879 | ||
| 996 | ‡2 NUKAT|nx2023731217 | ||
| 996 | ‡2 DNB|1134895801 | ||
| 996 | ‡2 DNB|1157415555 | ||
| 996 | ‡2 SELIBR|305368 | ||
| 996 | ‡2 BNC|981058601659106706 | ||
| 996 | ‡2 JPG|500021248 | ||
| 996 | ‡2 NUKAT|n 2017077398 | ||
| 996 | ‡2 NUKAT|n 2018104003 | ||
| 996 | ‡2 DNB|136080863 | ||
| 996 | ‡2 ISNI|0000000045107240 | ||
| 996 | ‡2 RERO|A003968582 | ||
| 996 | ‡2 ISNI|0000000071876780 | ||
| 996 | ‡2 ISNI|0000000450513568 | ||
| 996 | ‡2 DNB|133057593 | ||
| 996 | ‡2 PLWABN|9810693013305606 | ||
| 996 | ‡2 NUKAT|n 2009077141 | ||
| 996 | ‡2 ISNI|0000000390880904 | ||
| 996 | ‡2 DNB|1022448536 | ||
| 996 | ‡2 B2Q|0000288312 | ||
| 996 | ‡2 RERO|A011464776 | ||
| 996 | ‡2 DNB|119320193 | ||
| 996 | ‡2 BIBSYS|12038186 | ||
| 996 | ‡2 DNB|105536479X | ||
| 996 | ‡2 LC|n 2015037055 | ||
| 996 | ‡2 ISNI|0000000122423715 | ||
| 996 | ‡2 NUKAT|n 2011107427 | ||
| 996 | ‡2 DNB|1335486860 | ||
| 996 | ‡2 DNB|143296108 | ||
| 996 | ‡2 ISNI|0000000409775849 | ||
| 996 | ‡2 B2Q|0000895839 | ||
| 996 | ‡2 LC|no2005010590 | ||
| 996 | ‡2 RERO|A003968599 | ||
| 996 | ‡2 SZ|119320193 | ||
| 996 | ‡2 NUKAT|n 2021163281 | ||
| 996 | ‡2 NKC|jn20010525196 | ||
| 996 | ‡2 DNB|1067452699 | ||
| 996 | ‡2 ISNI|0000000113467636 | ||
| 996 | ‡2 RERO|A003968590 | ||
| 996 | ‡2 SUDOC|110740564 | ||
| 996 | ‡2 JPG|500094286 | ||
| 996 | ‡2 PLWABN|9810558659705606 | ||
| 996 | ‡2 DNB|133524140 | ||
| 996 | ‡2 ISNI|0000000015055961 | ||
| 996 | ‡2 BAV|495_39426 | ||
| 996 | ‡2 RERO|A013943138 | ||
| 996 | ‡2 BAV|495_39424 | ||
| 996 | ‡2 DNB|117304050 | ||
| 996 | ‡2 LC|no2022034762 | ||
| 996 | ‡2 PLWABN|9810530344905606 | ||
| 996 | ‡2 BIBSYS|90743359 | ||
| 996 | ‡2 CAOONL|ncf10951609 | ||
| 996 | ‡2 ISNI|0000000022021153 | ||
| 996 | ‡2 NII|DA10300394 | ||
| 996 | ‡2 DNB|1223547078 | ||
| 996 | ‡2 BIBSYS|1560455411072 | ||
| 996 | ‡2 BIBSYS|90340567 | ||
| 996 | ‡2 ISNI|0000000369092495 | ||
| 996 | ‡2 RERO|A024319429 | ||
| 996 | ‡2 DE633|pe50046346 | ||
| 996 | ‡2 NTA|252330846 | ||
| 996 | ‡2 SELIBR|411088 | ||
| 996 | ‡2 DNB|1050529294 | ||
| 996 | ‡2 NDL|00946942 | ||
| 996 | ‡2 DNB|142003727 | ||
| 996 | ‡2 J9U|987007409444505171 | ||
| 996 | ‡2 PLWABN|9810628344405606 | ||
| 996 | ‡2 DNB|122222903 | ||
| 996 | ‡2 SUDOC|152569596 | ||
| 996 | ‡2 LC|n 90667306 | ||
| 996 | ‡2 SUDOC|242749062 | ||
| 996 | ‡2 RERO|A003968588 | ||
| 996 | ‡2 RERO|A003968589 | ||
| 996 | ‡2 DNB|130509171X | ||
| 996 | ‡2 RERO|A003968587 | ||
| 996 | ‡2 ISNI|0000000000655542 | ||
| 996 | ‡2 LC|no2006095007 | ||
| 996 | ‡2 ISNI|000000007665276X | ||
| 996 | ‡2 PLWABN|9811518946805606 | ||
| 996 | ‡2 LC|n 91117520 | ||
| 996 | ‡2 LNB|LNC10-000350633 | ||
| 996 | ‡2 ISNI|0000000083979509 | ||
| 996 | ‡2 ISNI|0000000022656802 | ||
| 996 | ‡2 CAOONL|ncf11752982 | ||
| 996 | ‡2 BNCHL|10000000000000000016922 | ||
| 996 | ‡2 ISNI|0000000112055357 | ||
| 996 | ‡2 NKC|jn20000620422 | ||
| 996 | ‡2 ISNI|0000000481327792 | ||
| 996 | ‡2 NTA|074183559 | ||
| 996 | ‡2 LC|n 00008466 | ||
| 996 | ‡2 BNF|15614932 | ||
| 996 | ‡2 DNB|1162470119 | ||
| 996 | ‡2 DNB|1157914845 | ||
| 996 | ‡2 DNB|1054937753 | ||
| 996 | ‡2 ISNI|0000000067267632 | ||
| 996 | ‡2 NUKAT|n 2003048348 | ||
| 996 | ‡2 LC|n 2009054949 | ||
| 996 | ‡2 NUKAT|n 2021021932 | ||
| 996 | ‡2 NTA|292801211 | ||
| 996 | ‡2 LIH|LNB:___n__m_;=B1 | ||
| 996 | ‡2 DNB|1243792469 | ||
| 996 | ‡2 LC|nr2006024408 | ||
| 996 | ‡2 BNF|13901104 | ||
| 996 | ‡2 SUDOC|085850969 | ||
| 996 | ‡2 JPG|500067927 | ||
| 996 | ‡2 DBC|87097938860542 | ||
| 996 | ‡2 NKC|jx20100202031 | ||
| 996 | ‡2 PTBNP|236172 | ||
| 996 | ‡2 BNCHL|10000000000000000808143 | ||
| 996 | ‡2 LC|n 79131046 | ||
| 996 | ‡2 RERO|A017993370 | ||
| 996 | ‡2 ISNI|0000000400095783 | ||
| 996 | ‡2 BIBSYS|6099472 | ||
| 996 | ‡2 NTA|314092218 | ||
| 996 | ‡2 J9U|987007360314605171 | ||
| 996 | ‡2 PLWABN|9810629232605606 | ||
| 996 | ‡2 DNB|131605569 | ||
| 996 | ‡2 DNB|124494137 | ||
| 996 | ‡2 BIBSYS|1081243 | ||
| 996 | ‡2 ISNI|000000005417869X | ||
| 996 | ‡2 DBC|87097991255855 | ||
| 996 | ‡2 PLWABN|9810535909905606 | ||
| 996 | ‡2 DE633|pe30005702 | ||
| 996 | ‡2 NII|DA17703082 | ||
| 996 | ‡2 J9U|987007386469905171 | ||
| 996 | ‡2 ISNI|0000000377445561 | ||
| 996 | ‡2 DNB|1050672372 | ||
| 996 | ‡2 LC|n 98037077 | ||
| 996 | ‡2 ISNI|0000000116185386 | ||
| 996 | ‡2 SELIBR|218027 | ||
| 996 | ‡2 DNB|170337200 | ||
| 996 | ‡2 LC|nr 96001463 | ||
| 996 | ‡2 NTA|071859594 | ||
| 996 | ‡2 DNB|1089578334 | ||
| 996 | ‡2 ISNI|0000000115690292 | ||
| 996 | ‡2 DNB|1169606806 | ||
| 996 | ‡2 LC|n 94069489 | ||
| 996 | ‡2 DNB|140286004 | ||
| 996 | ‡2 PLWABN|9814276089505606 | ||
| 996 | ‡2 BIBSYS|90528178 | ||
| 996 | ‡2 SUDOC|032907958 | ||
| 996 | ‡2 DNB|141785047 | ||
| 996 | ‡2 SUDOC|035053607 | ||
| 996 | ‡2 SUDOC|07515658X | ||
| 996 | ‡2 DNB|125486898 | ||
| 996 | ‡2 RERO|A003968654 | ||
| 996 | ‡2 NTA|254927793 | ||
| 996 | ‡2 DE633|pe51016343 | ||
| 996 | ‡2 LC|n 81142133 | ||
| 996 | ‡2 NUKAT|n 2015008874 | ||
| 996 | ‡2 NII|DA07370110 | ||
| 996 | ‡2 SUDOC|203117344 | ||
| 996 | ‡2 ISNI|0000000080537262 | ||
| 996 | ‡2 PLWABN|9810542383105606 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
